NRSN
Price
$0.38
Change
+$0.03 (+8.57%)
Updated
Aug 21 closing price
Capitalization
14.21M
10 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$0.39
Change
-$0.01 (-2.50%)
Updated
Aug 21 closing price
Capitalization
2.19M
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRSN vs SLXN

NRSN vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRSN vs. SLXN commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRSN is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (NRSN: $0.38 vs. SLXN: $0.39)
Brand notoriety: NRSN and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRSN: 64% vs. SLXN: 70%
Market capitalization -- NRSN: $14.21M vs. SLXN: $2.19M
NRSN [@Biotechnology] is valued at $14.21M. SLXN’s [@Biotechnology] market capitalization is $2.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRSN’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • NRSN’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, NRSN is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • NRSN’s TA Score: 4 bullish, 3 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NRSN and SLXN are a good buy in the short-term.

Price Growth

NRSN (@Biotechnology) experienced а -16.95% price change this week, while SLXN (@Biotechnology) price change was -6.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

NRSN is expected to report earnings on Sep 02, 2026.

SLXN is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($14.2M) has a higher market cap than SLXN($2.19M). NRSN YTD gains are higher at: -51.066 vs. SLXN (-97.947). NRSN has higher annual earnings (EBITDA): -8.55M vs. SLXN (-12.91M). SLXN has more cash in the bank: 2.41M vs. NRSN (666K). NRSN has less debt than SLXN: NRSN (19K) vs SLXN (1.99M). NRSN (0) and SLXN (0) have equivalent revenues.
NRSNSLXNNRSN / SLXN
Capitalization14.2M2.19M648%
EBITDA-8.55M-12.91M66%
Gain YTD-51.066-97.94752%
P/E RatioN/A0.00-
Revenue00-
Total Cash666K2.41M28%
Total Debt19K1.99M1%
TECHNICAL ANALYSIS
Technical Analysis
NRSNSLXN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
51%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
40%
MACD
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 3 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
Bullish Trend 24 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMR210.0115.71
+8.09%
Alpha Metallurgical Resources
KEP11.260.03
+0.27%
Korea Electric Power Corp
OIS8.65-0.05
-0.57%
OIL States International
SHFS0.17-0.01
-2.94%
SHF Holdings Inc
HMR1.35-0.10
-6.90%
Heidmar Maritime Holdings Corp

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with PBM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then PBM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+7.39%
PBM - NRSN
37%
Loosely correlated
+10.18%
SLXN - NRSN
32%
Poorly correlated
-1.23%
CTMX - NRSN
31%
Poorly correlated
-0.30%
LIMN - NRSN
30%
Poorly correlated
-98.17%
CGON - NRSN
28%
Poorly correlated
+2.83%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.23%
IMA - SLXN
62%
Loosely correlated
-3.16%
CELC - SLXN
50%
Loosely correlated
+3.27%
CDT - SLXN
44%
Loosely correlated
-4.35%
INKT - SLXN
36%
Loosely correlated
+4.99%
ENSC - SLXN
33%
Loosely correlated
-1.19%
More